(Q36463439)

14 August 2017

Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo (English)

1 reference

PMCID

352110

https://api.crossref.org/works/10.1128/AAC.11.6.956

14 August 2017

Synergy Between Ticarcillin and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae In Vitro and In Vivo (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.11.6.956

23 April 2023

main subject

Pseudomonas aeruginosa

0 references

0 references

1 reference

23 April 2023

author name string

K. R. Comber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

23 April 2023

M. J. Basker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

23 April 2023

C. D. Osborne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

23 April 2023

R. Sutherland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

23 April 2023

language of work or name

English

0 references

publication date

1 June 1977

1 reference

14 August 2017

9

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC352110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

https://europepmc.org/articles/PMC352110?pdf=render

23 April 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A406837

https://journals.asm.org/doi/pdf/10.1128/AAC.11.6.956

23 April 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.11.6.956

Antimicrobial Agents and Chemotherapy

23 April 2023

published in

1 reference

14 August 2017

11

1 reference

14 August 2017

956-964

1 reference

14 August 2017

6

1 reference

Effect of carbenicillin, gentamicin, and their combination on experimental Pseudomonas aeruginosa urinary tract infection

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Interactions of Carbenicillin and Ticarcillin with Gentamicin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352110

Synergy of Carbenicillin and Gentamicin in Experimental Infection with Pseudomonas

21 September 2018

1 reference

12 December 2020

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

12 December 2020

Laboratory and Clinical Conditions for Gentamicin Inactivation by Carbenicillin

1 reference

12 December 2020

Antimicrobial Activity of the Carbenicillin/Gentamicin Combination Against Gram-Negative Bacilli

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.11.6.956

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

352110